Vardenafil (Levitra/Staxyn): What People Actually Pay

How Much Does Generic Vardenafil Actually Cost in 2026?

The sticker price for brand Levitra sits well above what most patients end up paying. Generic vardenafil, approved by the FDA since 2018, has pushed real out-of-pocket costs down sharply for the standard 20 mg tablet.

At major chain pharmacies (CVS, Walgreens, Rite Aid), the cash price for a 30-count supply of generic vardenafil 20 mg ranges from $45 to $120 without any discount card. That comes out to roughly $1.50 to $4.00 per tablet. Using a GoodRx or RxSaver coupon drops the per-tablet cost to $2 to $4 at most locations. Costco and independent pharmacies tend to sit at the lower end. Sam's Club and Walmart have reported prices as low as $1.80 per tablet for 30 tablets with a coupon.

Brand-name Levitra, by contrast, lists at $900 or more for a 30-count prescription. Few patients pay this. Bayer discontinued active U.S. marketing of Levitra in 2023, and most prescriptions now fill as generic vardenafil automatically.

Staxyn, the orally disintegrating tablet (ODT) formulation dosed at 10 mg, remains significantly pricier because no generic ODT equivalent exists in the U.S. market. Patients report paying $45 to $65 per tablet out of pocket. The ODT version dissolves on the tongue without water, which some men prefer, but the cost difference is steep enough that many switch to standard tablets after trying it.

Insurance coverage varies. A 2023 analysis of pharmacy benefit designs found that most commercial plans place PDE5 inhibitors on Tier 3 or higher, with sildenafil (generic Viagra) as the preferred step-therapy agent 1. Patients who fail sildenafil or experience side effects can often get vardenafil covered with prior authorization. Medicare Part D plans typically exclude erectile dysfunction drugs entirely under the standard benefit, though some Medicare Advantage plans offer limited coverage.

Telehealth and Subscription Pricing

Online prescribing platforms have become one of the most common ways men access vardenafil, and they have compressed pricing even further.

Hims, Ro, and similar telehealth services offer generic vardenafil at $3 to $10 per dose through monthly subscription models. The consultation fee is typically bundled into the subscription. A standard plan might include 8 to 12 tablets per month for $30 to $60. Some platforms offer compounded vardenafil combinations (vardenafil plus oxytocin, for example) at higher price points of $50 to $90 per month.

HealthRX patients accessing vardenafil through our platform report average monthly costs that fall within this range, with the majority paying under $8 per dose including the prescriber visit. Patients who opt for 90-day supplies see additional per-tablet savings of 15 to 25 percent compared to monthly fills.

One consistent finding across Reddit threads (r/erectile_dysfunction, r/Testosterone) is that men are often surprised by how affordable generic vardenafil has become. A frequently upvoted comment pattern: users who delayed treatment for years because they assumed PDE5 inhibitors cost $30 or more per pill discover that generics have changed the math entirely.

What Drugs.com and Reddit Reviews Actually Say

User reviews paint a picture that aligns closely with clinical trial data, though with more texture around real-world conditions like timing, food interactions, and partner dynamics.

On Drugs.com, vardenafil carries an average rating of approximately 7.5 out of 10 across over 100 user-submitted reviews for erectile dysfunction. About 65% of reviewers rate it 7 or higher. The most common praise: reliable onset, fewer visual side effects compared to sildenafil, and good performance even after a moderate meal.

Negative reviews cluster around two themes. First, some users report that vardenafil "works but not as strongly" as sildenafil or tadalafil (Cialis). Second, nasal congestion and flushing bother a subset of men enough that they switch medications. A smaller group reports headache severe enough to discourage continued use.

Reddit discussions on r/erectile_dysfunction and r/Trt add useful context that formal reviews often miss. Users frequently compare vardenafil head-to-head with sildenafil and tadalafil in their own experience. The consensus from these threads (acknowledging obvious selection bias and small sample sizes) is that vardenafil occupies a middle position: faster than tadalafil, with fewer visual disturbances than sildenafil, but a shorter duration than tadalafil's 36-hour window.

One Reddit user on r/erectile_dysfunction described vardenafil as "the one that let me eat dinner and still have it work." This reflects clinical pharmacology: vardenafil's absorption is less affected by moderate-fat meals than sildenafil's, though high-fat meals still delay onset by about 60 minutes 2.

Clinical Efficacy: What the Trials Found

Real-world reviews exist within the context of rigorous trial data. The key registration trials for vardenafil established its efficacy across a broad population of men with ED, including difficult-to-treat subgroups.

Porst et al. (2003) published results from a randomized, double-blind, placebo-controlled trial (N=580) evaluating vardenafil 5 mg, 10 mg, and 20 mg in men with ED of various etiologies. The 20 mg dose improved the International Index of Erectile Function (IIEF) erectile function domain score by a mean of 9.4 points from baseline, compared to 3.7 points for placebo (P<0.001). Successful penetration attempts (SEP2) reached 80% with 20 mg versus 52% with placebo. Successful intercourse completion (SEP3) reached 65% versus 32% 2.

For men with diabetes, a population that often responds less robustly to PDE5 inhibitors, a dedicated trial by Goldstein et al. (2003, N=452) demonstrated that vardenafil 20 mg improved IIEF-EF scores by 6.6 points versus 1.4 for placebo (P<0.001). SEP3 rates were 49% versus 23% 3. These numbers are lower than the general-population results, but the relative improvement remains clinically meaningful.

A meta-analysis by Yuan et al. (2013) pooling data from 10 randomized controlled trials (total N=4,623) confirmed that vardenafil significantly improved all primary efficacy endpoints compared to placebo, with adverse event rates comparable to other PDE5 inhibitors 4. The most common treatment-emergent side effects were headache (10 to 15%), flushing (8 to 12%), rhinitis (5 to 9%), and dyspepsia (3 to 6%).

The American Urological Association (AUA) guideline on ED (2018, amended 2023) lists all PDE5 inhibitors, including vardenafil, as first-line pharmacotherapy with equivalent recommendation strength. The guideline notes that choice among agents should be driven by patient preference, cost, and side-effect profile rather than efficacy differences 5.

How Vardenafil Compares to Sildenafil and Tadalafil on Price

Cost comparison drives many prescribing decisions. Here is where vardenafil sits relative to its PDE5 inhibitor competitors in 2026.

Generic sildenafil (20 mg or 100 mg) remains the cheapest option. Coupon prices run as low as $0.30 to $2.00 per tablet for the 100 mg dose. This price advantage is the primary reason insurance plans designate sildenafil as preferred. Generic tadalafil (5 mg daily or 20 mg as-needed) costs $0.50 to $5.00 per tablet with coupons.

Generic vardenafil falls between the two at $2 to $6 per tablet for most patients. The price gap has narrowed substantially since 2020, when vardenafil generics were still relatively new. Multiple generic manufacturers now produce vardenafil, and competition has driven prices closer to sildenafil's range at high-volume pharmacies.

For patients paying entirely out of pocket, the annual cost difference between daily tadalafil 5 mg (approximately $180 to $600 per year) and as-needed vardenafil 20 mg used twice weekly ($200 to $625 per year) is often modest enough that the choice comes down to lifestyle preference rather than pure economics.

Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and former chair of the AUA ED guideline panel, has noted: "All three major PDE5 inhibitors are effective first-line treatments. The choice should be individualized based on the patient's sexual activity patterns, comorbidities, and tolerance of side effects" 5.

Side Effects: What Users Report vs. What Trials Measured

Clinical trials and user reviews diverge most visibly around side effects. Not because users report different adverse events, but because they weight them differently.

In trials, headache is the most frequently reported side effect at 10 to 15% across doses 4. User reviews confirm this but rarely cite headache as a reason for discontinuation. Flushing (8 to 12% in trials) gets more attention on forums; men describe facial redness that can be socially noticeable and awkward during intimate encounters.

Nasal congestion, reported at 5 to 9% in trials, generates disproportionate frustration in user reviews. Multiple Drugs.com reviewers describe "stuffed-up nose that kills the mood." This side effect appears more bothersome in practice than its moderate trial incidence might suggest.

Visual disturbances (blue-tinted vision, light sensitivity) are far less common with vardenafil than with sildenafil. This difference reflects vardenafil's lower affinity for PDE6, the phosphodiesterase isoenzyme expressed in retinal photoreceptors 6. Reddit users who have tried both medications frequently cite this as vardenafil's primary advantage.

Rare but serious adverse events include QTc prolongation. Vardenafil's prescribing information carries a specific warning about avoiding the drug in patients taking Class IA or III antiarrhythmics, and in those with congenital long QT syndrome 7. This distinguishes vardenafil from sildenafil and tadalafil, which do not carry the same cardiac conduction warning. Prescribers should obtain a baseline ECG in patients with risk factors.

Timing, Food, and Alcohol: Practical Tips from Users

The practical details of how men use vardenafil day-to-day fill hundreds of forum threads and offer guidance that prescribing information alone cannot.

Most users report taking vardenafil 30 to 60 minutes before anticipated sexual activity. A common suggestion on Reddit: "Take it about 45 minutes before and you'll be in the sweet spot." The FDA-approved labeling recommends taking vardenafil approximately 60 minutes before activity, with efficacy demonstrated as early as 25 minutes in some trials 7.

Food interaction is a frequent discussion point. The pharmacokinetic data show that a high-fat meal (>57% fat) reduces vardenafil Cmax by 18 to 50%, though total absorption (AUC) is not significantly changed 2. Users translate this as: "A regular dinner is fine, but skip the cheeseburger and fries right before." Moderate alcohol (one to two drinks) does not appear to reduce efficacy in user reports, though the prescribing information notes that excessive alcohol can increase the risk of orthostatic hypotension.

Dose splitting is another common user practice. Some men report cutting 20 mg tablets in half and finding 10 mg sufficient. This is pharmacologically reasonable (10 mg and 20 mg are both approved doses), and it halves per-dose cost. Prescribers can write for 20 mg tablets with instructions to take half, effectively doubling the supply from each prescription.

The 2005 European Association of Urology (EAU) guideline on ED management recommends that patients try a PDE5 inhibitor at least 6 to 8 times before concluding it is ineffective, as initial anxiety and incorrect timing account for many early failures 8. Reddit threads confirm this pattern: multiple users describe poor initial experiences followed by success once they adjusted timing and managed expectations.

Who Should Consider Vardenafil Over Other Options

Vardenafil occupies a specific niche that makes it the best fit for certain patient profiles.

Men who experience blue vision or visual disturbances on sildenafil are natural candidates for switching to vardenafil, given its lower PDE6 cross-reactivity 6. Men who prefer as-needed dosing but find sildenafil too affected by food intake may prefer vardenafil's more forgiving absorption profile with moderate meals.

Men with diabetes-related ED have specific trial evidence supporting vardenafil. The Goldstein et al. (2003) diabetic-ED trial demonstrated that vardenafil's efficacy persisted even in patients with HbA1c levels above 8%, a population that often requires dose optimization 3.

Patients who need the extended window of tadalafil (up to 36 hours) or who prefer daily low-dose therapy will generally be better served by tadalafil 5 mg daily. Vardenafil's 4 to 5 hour window requires more precise timing.

Men taking alpha-blockers for benign prostatic hyperplasia should note that vardenafil requires a 6-hour separation from alpha-blocker dosing and should be started at the lowest dose (5 mg) per FDA labeling 7.

Selection Bias and Limitations of User Reviews

Every synthesis of user reviews requires a candid discussion of what these data cannot tell us.

Online reviews (Drugs.com, Reddit, Trustpilot) represent a self-selected population. People who have strong experiences, either very positive or very negative, are more likely to post. The true average experience is probably less dramatic than the review population suggests.

Sample sizes are small. Drugs.com has approximately 100 to 150 vardenafil reviews. Reddit threads discussing vardenafil specifically (not PDE5 inhibitors generally) number in the low hundreds. These are anecdotes, not epidemiological data.

Demographic data is absent. We do not know the ages, comorbidities, concomitant medications, or ED severity of most reviewers. A 35-year-old with performance anxiety and a 65-year-old with diabetes and vascular disease will have different response profiles, but their reviews sit side by side without context.

Publication bias also applies: men whose vardenafil prescription works well and becomes routine are less likely to post about it than men who had a notable positive or negative first experience. The Porst et al. trial's 65% SEP3 success rate at 20 mg 2 is probably a more reliable estimate of population-level efficacy than any review aggregation.